WELL Health Technologies Corp. (TSX:WELL)
4.040
+0.040 (1.00%)
Jul 31, 2026, 4:00 PM EST
WELL Health Technologies Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,032 | 1,013 | 1,709 | 929 | 656 | 1,027 | |
Market Cap Growth | -12.19% | -40.69% | 83.84% | 41.65% | -36.10% | -21.74% |
Enterprise Value | 1,870 | 1,770 | 2,112 | 1,391 | 1,049 | 1,457 |
Last Close Price | 4.04 | 3.99 | 6.86 | 3.85 | 2.84 | 4.91 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 38.23 | - | 52.77 | - | - | - |
Forward PE | 17.85 | 41.96 | 226.40 | 196.02 | 196.02 | 196.02 |
PEG Ratio | - | 0.90 | 9.06 | - | - | - |
PS Ratio | 0.70 | 0.72 | 1.86 | 1.20 | 1.15 | 3.40 |
PB Ratio | 0.99 | 1.17 | 1.97 | 1.21 | 0.90 | 1.66 |
P/FCF Ratio | 14.62 | 10.78 | - | 15.94 | 9.35 | 52.43 |
P/OCF Ratio | 8.93 | 8.31 | 179.46 | 13.99 | 8.57 | 46.12 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.27 | 1.26 | 2.30 | 1.79 | 1.84 | 4.82 |
EV/EBITDA Ratio | 10.12 | 10.27 | 50.16 | 14.50 | 13.36 | 57.30 |
EV/EBIT Ratio | 22.00 | 22.55 | - | 39.56 | 44.98 | - |
EV/FCF Ratio | 26.49 | 18.82 | - | 23.84 | 14.95 | 74.38 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.53 | 0.43 | 0.41 | 0.48 | 0.42 | 0.55 |
Debt / EBITDA Ratio | 3.64 | 3.49 | 10.09 | 4.44 | 4.57 | 15.81 |
Debt / FCF Ratio | 8.12 | 6.39 | - | 7.31 | 5.11 | 20.52 |
Net Debt / Equity Ratio | 0.62 | 0.54 | 0.34 | 0.50 | 0.42 | 0.55 |
Net Debt / EBITDA Ratio | 2.92 | 2.71 | 6.97 | 3.99 | 3.94 | 13.37 |
Net Debt / FCF Ratio | 6.51 | 4.97 | -43.77 | 6.56 | 4.41 | 17.36 |
Asset Turnover | 0.69 | 0.72 | 0.57 | 0.57 | 0.44 | 0.39 |
Inventory Turnover | 333.79 | 303.08 | 287.61 | 316.70 | 245.81 | 144.23 |
Quick Ratio | 0.69 | 0.85 | 0.83 | 1.20 | 0.94 | 0.94 |
Current Ratio | 0.83 | 1.03 | 0.91 | 1.52 | 1.11 | 1.04 |
Return on Equity (ROE) | 3.73% | 0.42% | 3.19% | 2.00% | 2.45% | -6.76% |
Return on Assets (ROA) | 3.93% | 3.38% | -6.08% | 2.20% | 1.91% | -2.10% |
Return on Invested Capital (ROIC) | 5.22% | 4.56% | -7.82% | 2.55% | 2.29% | -2.71% |
Return on Capital Employed (ROCE) | 4.93% | 4.96% | -2.22% | 2.84% | 2.00% | -1.91% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.60% | - | 1.90% | 0.00% | 0.00% | - |
FCF Yield | 6.84% | 9.28% | - | 6.28% | 10.69% | 1.91% |
Buyback Yield / Dilution | -2.13% | 0.73% | -7.66% | -7.18% | -15.61% | -42.56% |
Total Shareholder Return | -2.13% | 0.73% | -7.66% | -7.18% | -15.61% | -42.56% |